000 01330 a2200385 4500
005 20250513193235.0
264 0 _c19991116
008 199911s 0 0 eng d
022 _a0306-5251
024 7 _a10.1046/j.1365-2125.1999.00006.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAitchison, K J
245 0 0 _aFailure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cSep 1999
300 _a388-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlleles
650 0 4 _aAntipsychotic Agents
_xmetabolism
650 0 4 _aCytochrome P-450 CYP2D6
_xgenetics
650 0 4 _aHumans
650 0 4 _aHydroxylation
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aTreatment Failure
700 1 _aMunro, J
700 1 _aWright, P
700 1 _aSmith, S
700 1 _aMakoff, A J
700 1 _aSachse, C
700 1 _aSham, P C
700 1 _aMurray, R M
700 1 _aCollier, D A
700 1 _aKerwin, R W
773 0 _tBritish journal of clinical pharmacology
_gvol. 48
_gno. 3
_gp. 388-94
856 4 0 _uhttps://doi.org/10.1046/j.1365-2125.1999.00006.x
_zAvailable from publisher's website
999 _c10467218
_d10467218